GLP-1 medications like semaglutide and tirzepatide have produced clinical trial results previously only associated with bariatric surgery and access to these medications through medically supervised programs is now widely available
Product launches targeting this group increased by 21.4% year-on-year, with brands offering modular kits and meal systems tailored to midlife users
The FDA approved zenocutuzumabnow to be marketed as Bizengriunder its accelerated pathway
In West Lafayette, Indiana, type 2 diabetes management requires in-person appointments, lab work, and monitoring, which can be challenging through telehealth
Look for lyophilized white powder free of clumping or discoloration, which may indicate degradation
Routine activated-charcoal use for sulfur burps is not well established